| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H20ClN3O |
| Molar mass | 341.84 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Saripidem is asedative andanxiolytic drug in theimidazopyridine family, which is related to the better known drugszolpidem andalpidem.
Saripidem has a similar pharmacological profile to thebenzodiazepine family of drugs including sedative and anxiolytic properties, but itschemical structure is quite different from that of the benzodiazepine drugs, and saripidem is described as anonbenzodiazepine.
The mechanism of action by which saripidem produces its sedative and anxiolytic effects is by modulating the benzodiazepine binding site onGABAA receptors, however unlike many older GABAAagonists, saripidem is highly subtype selective and binds primarily to the ω1 subtype.[1]